Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06540495 · ClinicalTrials.gov registry record · NA

Virtual Personalized Exercise Program for Lung Cancer Patients

A NA study of Lung Cancer, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06540495 is a NA study of Lung Cancer that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 60 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06540495, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise program provided by Salaso, with the goal of improving functional status and outcomes. This study will assess the feasibility and usability of a virtual exercise platform designed for lung cancer subjects. Subjects will be referred to physical therapy and rehabilitation medicine doctors for evaluation and enrolment in a virtual exercise program tailored specifically to their needs. The virtual exercise program will be available on a digital platform accessible through a personal device. Subjects will undergo a pulmonary function test if not previously completed within 3 months of signing consent, a Six minute walk test (6MWT) and the Sit to Stand Test (STS) at the start and end of the 12- month program. Subjects will also be asked to complete quality of life FACT-L and the Patient Satisfaction questionnaires at 1 month, 3-months, 6-months, and 12-months. Patient satisfactions questionnaires include the System Usability Scale, Net Promotor Score (NPS), and the Technology Acceptance Model. Physicians will also complete a provider satisfaction questionnaire at 1 month, 6 months, 12 months, and 24 months from the time their first patient is enrolled. Subject participation in the trial will last 12 months from the time the subject starts utilizing the platform. If we find that the platform is accepted by subjects and is found to be feasible, a future randomized study will be developed to follow. Eligibility criteria (note that subjects will be allowed to be enrolled in the program as long as it is within 3 weeks of starting treatment): i. Subjects with Non-small cell lung cancer who belong to any of the three cohorts below ii. Have an ECOG PS of 0-2 iii. Can provide informed consent iv. Can engage in a virtual exercise platform v. Commit to all study procedures as per protocol vi. Are deemed appropriate for virtual exercise program by the PM\&R team T

Conditions Studied

Interventions

  • BEHAVIORAL Salaso Virtual Exercise Program

Study Locations (1)

New York

  • Northwell Health - New Hyde Park

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-06-03
Est. Completion 2025-06-30
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT06540495

The ClinicalTrials.gov registry entry for NCT06540495 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Salaso Virtual Exercise Program is the first listed.

NCT06540495 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06540495 about?

NCT06540495 is a clinical study titled "Virtual Personalized Exercise Program for Lung Cancer Patients". This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise program provided by Salaso, with the goal of improving functional status and outcomes. This study will assess the feasibility and usability of a virtual exercise platform designed f...

What is the current status of trial NCT06540495?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-06-03. Estimated completion is 2025-06-30.

What conditions does trial NCT06540495 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06540495?

The interventions under investigation include: Salaso Virtual Exercise Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06540495?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06540495 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.